Interpace Diagnostics

9:30 AM - 9:45 AM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
Interpace is a leader in enabling personalized medicine, offering advanced diagnostics, and providing molecular markers, data solutions and biopharma services. Our new business model leverages disease-specific, unique data and specialized service offerings along the therapeutic value chains from early diagnosis and prognostic planning to targeted therapeutic applications.

Ticker:
IDXG
Exchange:
NASDAQ
Company Type:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Clinical Utility Studies for Barregen
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided